Citadel Advisors
CLBT icon

Citadel Advisors’s Cellebrite CLBT Stock Holding History

Citadel Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.05M Buy
366,700
+19,500
+6% +$294K ﹤0.01% 4316
2025
Q4 		$6.26M Buy
347,200
+195,400
+129% +$3.51M ﹤0.01% 3942
2025
Q3 		$2.81M Buy
151,800
+91,800
+153% +$1.44M ﹤0.01% 5418
2025
Q2 		$960K Buy
60,000
+11,900
+25% +$212K ﹤0.01% 7200
2025
Q1 		$935K Buy
48,100
+20,300
+73% +$427K ﹤0.01% 7105
2024
Q4 		$612K Buy
27,800
+23,700
+578% +$456K ﹤0.01% 8107
2024
Q3 		$69K Buy
4,100
+1,900
+86% +$28.2K ﹤0.01% 11577
2024
Q2 		$26.3K Sell
2,200
-7,100
-76% -$79.3K ﹤0.01% 12395
2024
Q1 		$103K Buy
9,300
+8,600
+1,229% +$87.8K ﹤0.01% 11321
2023
Q4 		$6.06K Sell
700
-2,200
-76% -$17.1K ﹤0.01% 13379
2023
Q3 		$22.2K Buy
+2,900
New +$21.8K ﹤0.01% 12542
2023
Q1 		– Sell
-18,800
Closed -$82K – 14796
2022
Q4 		$82K Sell
18,800
-700
-4% -$3.13K ﹤0.01% 11495
2022
Q3 		$76K Sell
19,500
-1,500
-7% -$7.52K ﹤0.01% 11312
2022
Q2 		$107K Buy
+21,000
New +$109K ﹤0.01% 11345
2022
Q1 		– Sell
-32,300
Closed -$259K – 13679
2021
Q4 		$259K Buy
32,300
+12,700
+65% +$120K ﹤0.01% 11260
2021
Q3 		$182K Buy
+19,600
New +$205K ﹤0.01% 12113

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's CLBT Position: Q1 2026 in Review

Citadel Advisors increased its Cellebrite (CLBT) stake by 174% in Q1 2026, buying an estimated $13.8M and bringing the position to 1,436,201 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Citadel Advisors first reported a position in CLBT in Q3 2021 and has held it in 19 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Citadel Advisors held 1,436,201 shares of Cellebrite worth $19.8M as of Q1 2026.
  • Citadel Advisors bought 912,442 Cellebrite shares in Q1 2026, an estimated $13.8M.
  • Cellebrite made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2357 holding.
  • Citadel Advisors first reported a position in Cellebrite in Q3 2021 and has held it in 19 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.